Arun D. Pherwani

Arun D. Pherwani

Auto-generated profile, based on publicly available information

Arun D. Pherwani

Keele University School of Medicine, University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2024 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
APArun D Pherwani
Arun D Pherwani
AJAmundeep S Johal
Amundeep S Johal
DCDavid A Cromwell
David A Cromwell
JBJonathan R Boyle
Jonathan R Boyle
ZSZoltan Szeberin
Zoltan Szeberin
JBJacob William Budtz-Lilly
Jacob William Budtz-Lilly
To determine the peri-operative mortality for intact and ruptured abdominal aortic aneurysm (AAA) repair in 10 countries and to compare practice and outcomes over a 6 year period by age, sex, and geographical location. This VASCUNET study used prospectively collected data from vascular registries in 10 countries on primary repair of intact and ruptured AAAs undertaken between January 2014 and December 2019. The primary outcome was peri-operative mortality (30 day or in hospital). Logistic regression models were used to estimate the association between peri-operative mortality and patient characteristics and type of procedure. Factors associated with the use of endovascular aortic aneurysm repair (EVAR) were also evaluated. The analysis included 50 642 intact and 9 453 ruptured AAA repairs. The proportion of EVARs for intact repairs increased from 63.4% in 2014 to 67.3% in 2016 before falling to 62.3% in 2019 (p < .001), but practice varied between countries. EVAR procedures were more common among older patients (p < .001) and men (p < .001). Overall peri-operative mortality after intact AAA repair was 1.4% (95% confidence interval [CI] 1.3 - 1.5%) and did not change over time. Mortality rates were stable within countries. Among ruptured AAA repairs, the proportion of EVARs increased from 23.7% in 2014 to 35.2% in 2019 (p < .001). The average aortic diameter was 7.8 cm for men and 7.0 cm for women (p < .001). Overall peri-operative mortality was 31.3% (95% CI 30.4 - 32.2%); the rates were 36.0% (95% CI 34.9 - 37.2%) for open repair and 19.7% (95% CI 18.2 - 21.3%) for EVAR. This difference and shift to EVAR reduced peri-operative mortality from 32.6% (in 2014) to 28.7% (in 2019). The international practice of intact AAA repair was associated with low mortality rates in registry reported data. There remains variation in the use of EVAR for intact AAAs across countries. Overall peri-operative mortality remains high after ruptured AAA, but an increased use of EVAR has reduced rates over time.

23 July 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
CECristina Lopez Espada
Cristina Lopez Espada
CBChristian-Alexander Behrendt
Christian-Alexander Behrendt
KMKevin Mani
Kevin Mani
Mario D’OriaMario D’Oria
Mario D’Oria
TLThomas Lattman
Thomas Lattman
JBJacob William Budtz-Lilly
Jacob William Budtz-Lilly

23 July 2024 in Circulation
Verified
Journal Article
Closed access
QLQiuju Li
Qiuju Li
PBPanagiota Birmpili
Panagiota Birmpili
EAEleanor Atkins
Eleanor Atkins
AJAmundeep S. Johal
Amundeep S. Johal
SWSam Waton
Sam Waton
DCDavid A. Cromwell
David A. Cromwell
BACKGROUND: The aim of this study was to investigate the illness trajectories of patients with peripheral artery disease (PAD) after revascularization and estimate the independent risks of major amputation and death (from any cause) and their interaction. METHODS: Data from Hospital Episode Statistics Admitted Patient Care were used to identify patients (≥50 years of age) who underwent lower limb revascularization for PAD in England from April 2013 to March 2020. A Markov illness–death model was developed to describe patterns of survival after the initial lower limb revascularization, if and when patients experienced major amputation, and survival after amputation. The model was also used to investigate the association between patient characteristics and these illness trajectories. We also analyzed the relative contribution of deaths after amputation to overall mortality and how the risk of mortality after amputation was related to the time from the index revascularization to amputation. RESULTS: The study analyzed 94 690 patients undergoing lower limb revascularization for PAD from 2013 to 2020. The majority were men (65.6%), and the median age was 72 years (interquartile range, 64–79). One-third (34.8%) of patients had nonelective revascularization, whereas others had elective procedures. For nonelective patients, the amputation rate was 15.2% (95% CI, 14.4–16.0) and 19.9% (19.0–20.8) at 1 and 5 years after revascularization, respectively. For elective patients, the corresponding amputation rate was 2.7% (95% CI, 2.4–3.1) and 5.3% (4.9–5.8). Overall, the risk of major amputation was higher among patients who were younger, had tissue loss, diabetes, greater frailty, nonelective revascularization, and more distal procedures. The mortality rate at 5 years after revascularization was 64.3% (95% CI, 63.2–65.5) for nonelective patients and 33.0% (32.0–34.1) for elective patients. After major amputation, patients were at an increased risk of mortality if they underwent major amputation within 6 months after the index revascularization. CONCLUSIONS: The illness–death model provides an integrated framework to understand patient outcomes after lower limb revascularization for PAD. Although mortality increased with age, the study highlights patients <60 years of age were at increased risk of major amputation, particularly after nonelective revascularization.

30 April 2024 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
APAnna Louise Pouncey
Anna Louise Pouncey
LMLorenz Meuli
Lorenz Meuli
CLCristina Lopez-Espada
Cristina Lopez-Espada
JBJacob William Budtz-Lilly
Jacob William Budtz-Lilly
JBJonathan R Boyle
Jonathan R Boyle
SWSam Waton
Sam Waton
Vascular surgery registries report on procedures and outcomes to promote patient safety and drive quality improvement. International registries have significantly contributed to the VASCUNET collaborative abdominal aortic aneurysm (AAA) outcome projects. This scoping review aimed to outline the national registries in vascular surgery that currently participate in the VASCUNET collaborative AAA projects. A scoping review of all published VASCUNET AAA studies and validation reports between 1997 and 2024 was undertaken. A survey was conducted among representatives of the international vascular registries contributing to VASCUNET collaborative AAA projects. Currently, vascular registries from 10 countries (Australia, Denmark, Finland, Hungary, Iceland, New Zealand, Norway, Sweden, Switzerland, and the UK) contribute to the current VASCUNET collaborative AAA project, of which eight have national coverage. In the past, three countries (Germany, Malta, and Italy) have participated in previous VASCUNET AAA projects, and a further three countries (Serbia, Greece, and Portugal) have planned participation in future projects. External validity is high for all current registries, with most reporting rates of > 90%. The majority have internal validation processes to assess data accuracy. VASCUNET mediated validation has also been performed by the consortium for five countries to date (Hungary, Sweden, Denmark, Malta, and Switzerland), for which a high degree of external and internal validity was identified. Most registries have established mechanisms for data linkage with national administrative datasets or insurance claims datasets, and contribute to quality improvement through regular reporting to participating centres. National vascular registries from nations participating in the VASCUNET collaborative AAA projects are largely comprehensive, with high case ascertainment rates and good quality data with internal quality assurance. This provides a template for new registries wishing to join the VASCUNET collaboration and a benchmark for future research.

10 February 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PBPanagiota Birmpili
Panagiota Birmpili
QLQiuju Li
Qiuju Li
AJAmundeep S. Johal
Amundeep S. Johal
SWSam Waton
Sam Waton
EAEleanor Atkins
Eleanor Atkins
DCDavid A. Cromwell
David A. Cromwell

9 May 2023 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Open access
PBPanagiota Birmpili
Panagiota Birmpili
DCDavid A. Cromwell
David A. Cromwell
QLQiuju Li
Qiuju Li
AJAmundeep S. Johal
Amundeep S. Johal
EAEleanor Atkins
Eleanor Atkins
SNSandip Nandhra
Sandip Nandhra
Anaemia is common among patients undergoing surgery, but its association with post-operative outcomes in patients with peripheral arterial disease (PAD) is unclear. The aim of this observational population based study was to examine the association between pre-operative anaemia and one year outcomes after surgical revascularisation for PAD. This study used data from the National Vascular Registry, linked with an administrative database (Hospital Episode Statistics), to identify patients who underwent open surgical lower limb revascularisation for PAD in English NHS hospitals between January 2016 and December 2019. The primary outcome was one year amputation free survival. Secondary outcomes were one year re-admission rate, 30 day re-intervention rate, 30 day ipsilateral major amputation rate and 30 day mortality. Flexible parametric survival analysis and generalised linear regression were performed to assess the effect of anaemia on one year outcomes. The analysis included 13 641 patients, 57.9% of whom had no anaemia, 23.8% mild, and 18.3% moderate/severe anaemia. At one year follow up, 80.6% of patients were alive and amputation free. The risk of one year amputation/death was elevated in patients with mild anaemia (adjusted HR 1.3; 95% CI 1.15 - 1.41) and moderate/severe anaemia (aHR 1.5; 1.33 - 1.67). Patients with moderate/severe anaemia experienced more re-admissions over one year (adjusted IRR 1.31; 1.26 - 1.37) and had higher odds of 30 day re-interventions (aOR 1.22; 1.04 - 1.45), 30 day ipsilateral major amputation (aOR 1.53; 1.17 - 2.01), and 30 day mortality (aOR 1.39; 1.03 - 1.88) compared with patients with no anaemia. Pre-operative anaemia is associated with lower one year amputation free survival and higher one year re-admission rates following surgical revascularisation in patients with PAD. Research is required to evaluate whether interventions to correct anaemia improve outcomes after lower limb revascularisation.